FDA Approves First Needle-Free Glucagon to Treat Severe Hypoglycemia

, , , , , , , , , ,

The FDA approved Eli Lilly’s Baqsimi (glucagon) nasal powder 3 mg to treat severe hypoglycemia in diabetics 4 years of age and older.

Read more
/by